Today's Health News

Most Inflammatory, Cardiac Manifestations of MIS-C Resolve

Most inflammatory markers normalized by one to four weeks; however, elevated double-negative T cells seen in 92 percent at one to four months

Survival Up for Multiple Cancer Types for Teens, Young Adults

Limited or no improvement seen in female breast cancer, cervical cancer, ovarian cancer, and bone and joint sarcomas

Vaccinations Start to Climb in States Hit Hard by Delta Variant

Variant, which first emerged in India, now accounts for an estimated 83 percent of coronavirus samples genetically identified in the United States

Circulation of Respiratory Viruses Low During COVID-19 Pandemic

Influenza activity decreased in March 2020, remained low through May 2021; decrease seen in other viruses, with no increase until Spring 2021

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices

Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery

Prior Statin Use Linked to Reduced Risk for Death in COVID-19

Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension

2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth

Mortality due to COVID-19 had biggest effect on decline in life expectancy for both men and women, all races examined

Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC

No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease

Neutralizing Monoclonal Antibody Combo Treats Mild, Moderate COVID-19

For those at high risk, COVID-19-related hospitalization or death from any cause reduced with bamlanivimab/etesevimab versus placebo